BRAF and carcinoma: Despite the well characterized “adenoma-carcinoma sequence” [71], approximately 10–15% of sporadic CRCs originate from serrated polyps which have been identified as an alternative key pathway [72] that harbors, e.g., the CpG island methylator phenotype (CIMP), and its close relation to BRAF mutations [73].